The choice of antipsychotics in schizophrenia

    loading  Checking for direct PDF access through Ovid

Abstract

In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs, second-generation antipsychotics have emerged as the predominant treatment for schizophrenia. A new meta-analysis concludes that the difference in efficacy between newer and older agents is small, and the current classification scheme for antipsychotics does not survive close scrutiny.

Related Topics

    loading  Loading Related Articles